NEWS, REPORTS & POSITION STATEMENTS 1. Opportunities and insights from pharmaceutical companies on the current use of NAMs in nonclinical safety assessment To foster broader adoption of NAMs, the Biotechnology Innovation Organization surveyed pharma/biotech companies about NAM usage and collected […]
NEWS, REPORTS & POSITION STATEMENTS 1. India bioprinting push: New partnership with UK institutions The Indian Institute of Science (IISc) and Henry Royce Institute at the University of Manchester have signed a letter of intent to work together on advanced […]
NEWS, REPORTS & POSITION STATEMENTS 1. Europe’s first pan-European agentic infrastructure for biology At Franco-German Summit on Digital Sovereignty in Berlin, Owkin, together with leading academic partners Gustave Roussy (France) and Charité Comprehensive Cancer Center (Germany), announced a landmark initiative […]
NEWS, REPORTS & POSITION STATEMENTS 1. MPS are beating organoids and spheroids in the NAMs qualification race Last week, the FDA published four new LOI (Letter of Intent) determinations for the ISTAND Program; two acceptances and two rejections. There are […]
NEWS, REPORTS & POSITION STATEMENTS 1. F3OCI white paper 2025 The French Organoids and Organs-on-a-Chip Sector (F3OCI), co-piloted by BioValley France and NETRI for France Biotech, published its 2025 White Paper: an ambitious roadmap for structuring this strategic French sector serving […]